Results 131 to 140 of about 79,367 (221)

The impact of the COVID-19 pandemic on incidence and clinical presentation of thrombotic microangiopathies: data from a laboratory centralizing ADAMTS-13 testing in Quebec. [PDF]

open access: yesOrphanet J Rare Dis
Merlen C   +8 more
europepmc   +1 more source

Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics

open access: yesJournal of Thrombosis and Haemostasis, 2017
M. Saha, Jenny K. McDaniel, X. Zheng
semanticscholar   +1 more source

Depression and cognitive deficits as long‐term consequences of thrombotic thrombocytopenic purpura

open access: yesTransfusion, 2017
T. Falter   +10 more
semanticscholar   +1 more source

New Insights Into Renal Involvement During Immune-Mediated Thrombotic Thrombocytopenic Purpura. [PDF]

open access: yesKidney Int Rep
Robert M   +16 more
europepmc   +1 more source

Rituximab reduces risk for relapse in patients with thrombotic thrombocytopenic purpura.

open access: yesBlood, 2016
E. E. Page   +4 more
semanticscholar   +1 more source

The Prognostic Value of Platelet Kinetics Assessment in Pediatric Chronic Idiopathic Thrombocytopenic Purpura. [PDF]

open access: yesDiagnostics (Basel)
Igrutinovic N   +17 more
europepmc   +1 more source

Challenges in diagnosing thrombotic thrombocytopenic purpura. [PDF]

open access: yesHematol Transfus Cell Ther
Jacobs JW, Booth GS, Adkins BD.
europepmc   +1 more source

Home - About - Disclaimer - Privacy